Daniel E Frigo

23PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCardiology (incl. cardiovascular diseases)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Oct 15, 2026
Cardiometabolic health's influence on the efficacy of pre-operative hormone therapy for men with localized high-risk prostate cancer.

|Jul 27, 2026
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis.

|Jun 30, 2026
Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosis.

|Nov 07, 2025
Evaluating Clinical Tools to Monitor Cardiovascular Risk in Men With Prostate Cancer Receiving Hormone Therapy.

Neha Venkatesh, Pankaj Kumar Chauhan, Sagar S Mukhida

|May 13, 2025
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors.

Feiyu Chen, Haoyan Li, Yin Wang

|Jul 17, 2024
Body composition as a determinant of the therapeutic index with androgen signaling inhibition.

Andrew W Hahn, Rebecca S Tidwell, Patrick G Pilie

Pageof 4

Frequent Collaborators

5 joint publications

Andrew W Hahn

4 joint publications

Christopher J Logothetis

4 joint publications

Ana M Aparicio

3 joint publications

Sumit K Subudhi